fda approves first oral glp-1 obesity drug august 21 2025 Wegovy Pill Approved: What This Means for Your Care FDA approves new oral GLP-1
Description
Weight loss : While not the original purpose of these medications, many patients experience significant and sustained weight lossespecially those on higher-dose versions like Wegovy or Zepbound

SOURCE: Journal of the American Medical Association , May 22, 2024 What This Means For You GLP-1 meds for diabetes and weight loss are increasingly popular among teens and young adults.

Around a quarter (26%) of people diagnosed with heart disease have used GLP-1 medications, and 22% of people diagnosed as being overweight or obese say they have used them or are currently using them

GLP-1 receptor agonists cannot be used in combination with dipeptidyl-peptidase 4 inhibitors
Nie Q, Li M, Huang C, Yuan Y, Liang Q, Ma X, Qiu T, Li J

For a thorough look at the research, Dr